Introduction: Mesh-related complications from reconstructive surgery for pelvic organ prolapse are of international concern. The present study aimed to review the incidence, management, and surgical outcomes of mesh-related complications in a Chinese population compared with existing studies involving Western populations.
Introduction
Traditional repair of pelvic organ prolapse has a high recurrence risk of up to 30%, leading to development New knowledge added by this study • This is among the first studies to report the intermediate incidence and management outcomes of mesh-related complications in the Chinese population in Hong Kong.
• Transvaginal mesh surgery, coital activity, and obesity were associated with a higher rate of mesh exposure and subsequent need of re-operation.
• Vaginal excisions of exposed mesh were usually successful; this can be done as an out-patient procedure with satisfactory outcome.
• A high satisfaction rate (97%) was noted.
• Dyspareunia and pelvic pain were rare complaints among Chinese women after mesh surgery, despite being common in Western populations. Implications for clinical practice or policy • The rates of mesh exposure and re-operation for mesh-related complications tended to be lower for abdominal mesh surgery than for transvaginal mesh surgery, although the latter is less invasive and has a shorter operating time.
• Careful selection of patients, ie, patients with advanced stage of pelvic organ prolapse, older than 65 years, and sexually inactive, would benefit more from selecting transvaginal mesh surgery.
• Weight optimisation before operation may reduce mesh-related complications due to obesity. 
香港骨盤底器官脫垂人造纖維網重建手術引起的 相關併發症

=3.7；P=0.046）其人造纖維網移位發生率均較高。不論人造纖維網 相關的併發症如何，超過90%患者對手術結果表示滿意。
結論：人造纖維網移位和再次手術的發生率與文獻的結果一致，表明 中西方患者對此類手術的結果無顯著差異。 women after mesh reconstructive surgery, especially in Western populations. 4, 5 Sacrocolpopexy was formerly the gold standard treatment for apical compartment or vaginal vault prolapse and had adequate evidence and support. 3, 6 However, sacrocolpopexy has a longer learning curve and operating time than vaginal surgery. 3, 7 Transvaginal mesh surgery was promoted as a good alterative option in terms of anatomical correction and shorter operative time. 3, 7, 8 A previous report on transvaginal mesh surgery for pelvic organ prolapse showed a high rate of patient satisfaction and success in the Chinese population in Hong Kong. 9 The incidence of mesh exposure has been reported to be 2% to 12% in sacrocolpopexy, 1,2,10,11 and 2.7% to 24% in transvaginal mesh surgery. [12] [13] [14] [15] Most reports, including those from the United States Food and Drug Administration 4 and the New Zealand Accident Compensation Corporation, 5 have involved patients from Western countries and have advised caution regarding the use of transvaginal mesh. There is limited information on transvaginal mesh surgery in Asian populations. Ethnic differences have been suggested as a significant factor for explaining differences in prevalence of pelvic organ prolapse and in pelvic organ mobility. 16, 17 Possible differences in response and complications from mesh surgery in different populations may exist. Some studies have reported that mesh exposure usually occurs in the first few months after surgery 13, 14, 18, 19 but studies with a longer follow-up are required to confirm this. Most studies reporting mesh complications have focused on the time interval between insertion of mesh and excision of the exposed mesh instead of detection of mesh exposure. 20, 21 The exact location and size of the mesh exposure are sometimes inadequately reported. 14, 20 Many studies have investigated mesh-related complications from mesh reconstructive surgery for pelvic organ prolapse. However, there is limited information on such complications in Asian populations. The aim of the present study was to evaluate the incidence, management, and surgical outcomes of mesh-related complications from mesh reconstructive surgery for pelvic organ prolapse in a tertiary centre in a Chinese population in Hong Kong.
Methods
The present study was an observational cohort study conducted at the urogynaecology training centre at the Prince of Wales Hospital, Hong Kong. All patients receiving mesh reconstructive surgery for pelvic organ prolapse between 2005 and 2016 in the study centre were recruited. Those who did not return for any postoperative follow-up were excluded from the data analysis.
Laparoscopic sacrocolpopexy was offered to patients with vaginal vault prolapse. In patients with stage III/IV uterine prolapse, medically fit and sexually active, the option of concomitant vaginal hysterectomy with laparoscopic sacrocolpopexy was offered. Laparoscopic hystercolposacropexy was performed if patients requested uterine preservation. Transvaginal mesh surgery, either anterior, posterior, or total vaginal mesh, was available to patients with anterior and posterior compartment prolapse, at least stage III or above, who were aged ≥65 years, were more likely sexually inactive, or had recurrence of pelvic organ prolapse after previous sacrocolpopexy/hystercolposacropexy. Transvaginal mesh surgery was also offered with concomitant vaginal hysterectomy or with uterine preservation. Insertion of vaginal mesh in the posterior compartment was not performed after January 2013, after evidence was published that showed no improvement from posterior vaginal mesh compared with native tissue repair alone. 22, 23 Concomitant continence surgery in terms of midurethral sling or laparoscopic colposuspension was performed if patients had urodynamically confirmed stress incontinence. All operations were performed by urogynaecologists or by urogynaecology subspecialty trainees under direct supervision by urogynaecologists. All demographic data, intraoperative findings, and immediate postoperative events were documented in the patients' medical records.
Patients were followed up at 2 to 4 months and 12 months after surgery, then annually after that. Earlier follow-up was offered if the patient requested. During the follow-up consultation, the attending gynaecologist asked patients about vaginal bleeding, pain, dyspareunia, and the severity of any present symptoms. Vaginal examination was performed to determine whether there was recurrence of pelvic organ prolapse or mesh exposure, as recommended by International Continence Society (ICS) and the International Urogynecological Association (IUGA). 24, 25 Patients were asked to subjectively assess the treatment outcome during every postoperative clinic visit. Patients rated the outcome as "worse, same, or better" compared with their preoperative condition. Location, size, and area of mesh exposure were documented. Complications related directly to the insertion of mesh were classified according to the joint project of the IUGA and the ICS during the analysis of the database. 24 Vaginal oestrogen cream was offered to patients with mesh exposure if not contra-indicated. 26 The option of conservative management or surgical excision of exposed mesh was discussed with patients, depending on the severity, symptoms, and their wishes. Treatment outcome with or without mesh-related complications was also studied. All patients underwent the same study protocol and had the same postoperative assessment on mesh complications according to a standardised datasheet. The postoperative assessment was carried out by urogynaecologists or trained gynaecologists.
Different variables were studied to investigate any association with mesh complications. Patients were evaluated according to whether they received abdominal or transvaginal mesh surgery.
Statistical analyses
Data were analysed using the SPSS Windows version 22.0 (IBM Corp, Armonk [NY], United States). Descriptive analysis was used to study the demographics and incidence of mesh complications. Fisher's exact test, Chi squared test, student's t test, and Mann-Whitney U test were used for statistical comparisons between different study groups. A P value of <0.05 was considered statistically significant. Multiple logistic regression was performed for variables found to be statistically significant in univariate analysis; odds ratio (OR) and 95% confidence interval (CI) were also studied.
Results
A total of 280 Chinese women received mesh reconstructive surgery from March 2005 to December 2016. Four patients were lost to followup. Therefore, 276 (98.6%) patients were included for data analysis (Fig) .
The demographics and background data of the study population are presented in Table 1 . Abdominal mesh surgery and transvaginal mesh surgery, all with concomitant pelvic floor repair, were performed in 142 and 134 patients, respectively. Concomitant continence operation was performed in 81 (29.3%) patients. Mean follow-up duration was 40 ± 1.47 months (range, 1-131 months).
Mesh-related complications were identified in 22 (8.0%) patients, including vaginal mesh exposure in 20 (7.2%) patients and intra-operative and perioperative complications in one (0.4%) patient each ( Table 2) .
Intra-operatively, there was one bladder injury during insertion of inferior trocar of the anterior vaginal mesh. The involved trocar was immediately removed and re-inserted in another correct surgical plane. Cystoscopy showed a small site of bladder perforation without active bleeding nor urine leakage. No repair was necessary. No mesh material was seen inside bladder. The patient recovered uneventfully without other mesh-related complications in subsequent follow-up.
Perioperatively, one patient had mesh infection after anterior vaginal mesh repair with abscess formation in the vulva, requiring mesh removal 18 days after the primary operation. The infection subsided with antibiotics and drainage, but the patient passed away at 7 weeks postoperatively due to other medical morbidities.
The incidence of mesh exposure was 2.8% in abdominal and 11.9% in transvaginal mesh surgery (Table 2) . Mesh exposure was most commonly found in posterior vaginal wall (33.3%) followed by anterior vaginal wall (27.8%), middle part of vaginal vault (22.2%), left and right vaginal vault (16.7%). The mean ± standard deviation size of the exposed mesh was 1.2 ± 0.6 cm (range, 0.3-2 cm). Median duration from primary operation to the time of first detection of mesh exposure was 12 months (interquartile range [IQR]=4.8-32.8 months); the longest duration was 63 months. Median time of detection was 11.5 months (IQR=5.8-31.8 months) in transvaginal mesh surgery and 34.5 months (IQR=15.0-59.0 months) in abdominal mesh surgery (P=0.081; Table 2 ). All patients with mesh exposure presented with intermittent vaginal spotting and all involved only the vaginal epithelium. None complained of dyspareunia, or vaginal or pelvic pain, although half of them were sexually active.
Vaginal oestrogen cream was given to all 20 patients with mesh exposure; this treatment was successful in eight (40%) patients. Two others were asymptomatic and opted for conservative management. The remaining 10 required surgical excision of the exposed mesh. The main indication for re-operation was vaginal spotting; no re-operations were related to pelvic pain or dyspareunia. All surgical excisions of exposed mesh were performed vaginally under local anaesthesia on the same day, except for one patient who opted for general anaesthesia. The median time between primary operation to first surgical excision of exposed mesh was 14 months (IQR=8.8-37.3 months); the longest was 66 months. Mean ± standard deviation operating time for the surgical excisions of exposed mesh was short, around 20 ± 6 minutes (range, 10-30 minutes) with estimated blood loss of 2 to 10 mL. Three patients required repeated excisions with operating times of 22 ± 2 minutes (range, 20-23 minutes) and estimated blood loss of 7 to 12 mL. Another three, in whom mesh exposure remained after first excision, opted not to have a second excision because they were asymptomatic. Most (95%) patients were well at their latest follow-up. Clinical details of all the mesh-related complications are listed with IUGA/ ICS codes 24 in Table 3 . The relationships between various factors and mesh exposure were explored (Table 4) . Mesh exposure was more common in transvaginal than in abdominal mesh surgery (OR=4.7; 95% CI=1.5-14.3; P=0.007). Transvaginal mesh with posterior insertion was found to be associated with increased risks of mesh-related complications (OR=4.3; 95% CI=1.6-11.5; P=0.002). Total vaginal mesh surgery was also found to be a significant factor (OR=5.0; 95% CI=1.8-13.6; P=0.002). Coital activity (OR=2.8; 95% CI=1.1-6.9; P=0.03) and obesity (OR=4.7; 95% CI=1.5-14.4; P=0.007) were also found to be associated with mesh exposure. No other factors studied were associated with mesh exposure (Table 4) .
Multiple logistic regression was performed on these significant variables. This revealed that transvaginal mesh surgery (adjusted OR=6.1; 95% CI=1.6-16.1), coital activity (adjusted OR=5.4; 95% CI=1.8-16.1), and obesity (adjusted OR=3.7; 95% CI=1.0-13.3) remained the significant factors associated with mesh exposure (Table 4) .
Discussion
Our study aimed to evaluate the incidence of meshrelated complications from mesh reconstructive surgery for pelvic organ prolapse and associated surgical outcomes in a tertiary unit over the past 11 years. This objective was fulfilled with the study carried out according to its initial design.
The main mesh-related complication reported was vaginal mesh exposure, which is consistent with previous studies on mesh-related complications. 2, 4, 20 The findings in this study concur with other reports that the most important risk factor of mesh exposure is route of surgery. 11, 20 Total vaginal mesh repair was associated with a higher rate of mesh exposure than was anterior vaginal mesh insertion, in agreement with a previous study. 13 The posterior vagina was the most common site of mesh exposure in the present study; therefore, avoiding posterior vaginal mesh repair might reduce the incidence of mesh exposure. A lower rate of mesh exposure from transvaginal mesh surgery is expected in future if insertion of posterior vaginal mesh is stopped; studies will be required to confirm this. The rates of mesh exposure in transvaginal mesh surgery and in laparoscopic sacrocolpopexy in the present study were within the range of rates reported in the literature. The re-operation rates for mesh-related complication were similar to those reported in other studies: 2% to 13.2% for transvaginal 14, 20 and 1.3% to 5% for abdominal mesh surgery. 1, 20, 26 All mesh surgeries in the present study were performed by or with trained urogynaecologists, but that might not be the case in other hospitals. 14, 20, 21 Coital activity was associated with higher risks of mesh exposure, in agreement with other study populations. 12, 18, 20 Obesity is known to have many implications for health, including as an independent risk factor for perioperative surgical site infection in vaginal surgery, 27 although this is not mentioned specifically in other studies on mesh-related complications. Patients ought to be counselled to attempt weight reduction before a prolapse operation because weight loss might lower the risk of mesh-related complications, in addition to the general benefits of maintaining a body mass index in the normal range. Dyspareunia, pelvic, or vaginal pain are among the most common distressing symptoms reported in the literature 4, 11, 20, 21 but these were not reported in this study cohort. This might be explained by differences in the interpretation of 'discomfort' from mesh-related complications between Chinese and Western populations.
The median time between surgery and detection of mesh exposure in the present study was within the range reported in other studies. 12, 13, 17, 18 Mesh exposure tended to be found earlier in transvaginal than abdominal mesh surgery, but this difference was not significant. Patients should be informed about the possible symptoms of mesh exposure and advised to seek medical advice should they experience them. There was one mesh infection with abscess formation and one mild bladder injury over the 11 years of study. Otherwise there were no serious mesh-related complications, such as mesh exposure to the bladder or bowel, or spondylodiscitis. 15, 19, 21 Demographic differences were found between the two groups of patients receiving abdominal and transvaginal mesh surgery due to the different selection criteria, as anticipated from the beginning of the study design. Younger patients tend to have higher risks of re-interventions from mesh surgery. 28, 29 Thus, younger patients are more often offered abdominal instead of vaginal mesh surgery.
Concomitant vaginal hysterectomy and concomitant continence surgery were not associated with mesh complications in this study, consistent with one review on abdominal sacrocolpopexy 10 but in contrast to another. 11 Smoking has been found to be associated with mesh exposure. 12 However, the prevalence of smoking was low in this cohort and this association was not detected. Different ages have been found to be associated with higher risk of mesh exposure in other studies, 20, 26 but this was not confirmed in the present study population.
Strengths
The objective was clearly defined and fulfilled. The loss to follow-up rate was low (only 1.4%) and data collection was complete without missing data, reducing possible bias in results analysis. The high follow-up rate could be due to the low medical cost for follow-up and geographical convenience in Hong Kong. A search of the literature suggests that the present study is among the first with a low loss-tofollow-up rate investigating the incidence of meshrelated complications from mesh reconstructive surgery in a Chinese population.
Limitations
The 11-year duration of the present study, although long, could be too short for all complications or recurrences of mesh exposure to become apparent. No power calculation was used, because patients only with an advanced stage of pelvic organ prolapse are be offered mesh surgeries, and not all women with advanced pelvic organ prolapse opt for mesh surgery, knowing the possible risks. This study might be underpowered to detect other possible factors associated with mesh complications. However, this study can provide important information on the complications associated with mesh surgeries from a population that has not been well investigated.
This was a single-centre study with specific selection criteria for different routes of mesh surgery.
All types of mesh surgery for pelvic organ prolapse were performed by the urogynaecology team; this might limit the generalisability of the results to other centres in which operations are performed by non-urogynaecologists. 14, 20, 21 However, it is common practice in other study centres in Hong Kong for urogynaecologists or gynaecologists experiences in vaginal surgery to perform mesh surgery for pelvic organ prolapse.
The IUGA/ICS coding 24 for mesh-related complications was performed retrospectively during database analysis. However, all data needed for the coding were available. Finally, the followup assessment was performed by the same team of surgeons; this might lead to potential reporting bias (on the part of the patient and the clinician). However, the reporting of mesh exposure or complication was an objective clinical decision, with the use of a standardised datasheet and would not be largely affected.
Conclusions
Careful selection of patients and intensive training for surgeons would help to reduce the incidence of mesh-related complications from reconstructive surgery for pelvic organ prolapse. The present study found that the incidence of mesh-related complications and the re-operation rate after mesh surgery in Chinese women were consistent with those reported in the Western populations. The incidence of mesh-related complications tended to be lower after abdominal than after transvaginal mesh surgery. Pelvic pain and dyspareunia were rare complaints independent of the occurrence of mesh complications. Surgical outcomes after mesh surgery were satisfactory despite some cases of mesh exposure. Longer-term studies with more patients are needed before definitive conclusions can be drawn. 
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